Key facts
- GSK has acquired Nuvalent for $10bn to diversify its patent portfolio.
- Palantir is initiating legal action against London Mayor Sadiq Khan.
- The World Cup's potential to aid the struggling UK pub sector is examined.
In a recent episode of City AM's Business As Usual podcast, key business and market stories were discussed. Pharma giant GSK has finalized a $10bn deal to acquire the Boston-based firm Nuvalent, a move aimed at diversifying its patent portfolio. Additionally, AI firm Palantir is preparing to sue London Mayor Sadiq Khan concerning the cancellation of a police contract. The podcast also explored whether the upcoming World Cup could provide a much-needed boost to the UK's struggling pub industry.